INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 214 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.82 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $1 | -100.0% | 1,400 | -56.2% | 0.00% | – |
Q3 2022 | $8,000 | +14.3% | 3,200 | +39.1% | 0.00% | – |
Q2 2022 | $7,000 | +40.0% | 2,300 | -20.7% | 0.00% | – |
Q1 2022 | $5,000 | -98.7% | 2,900 | -97.0% | 0.00% | -100.0% |
Q4 2021 | $395,000 | +153.2% | 95,245 | +892.1% | 0.02% | +142.9% |
Q3 2021 | $156,000 | -3.7% | 9,600 | -5.0% | 0.01% | 0.0% |
Q2 2021 | $162,000 | -0.6% | 10,100 | +14.8% | 0.01% | -12.5% |
Q1 2021 | $163,000 | -6.9% | 8,800 | -21.6% | 0.01% | 0.0% |
Q4 2020 | $175,000 | -25.8% | 11,231 | -74.9% | 0.01% | -42.9% |
Q3 2020 | $236,000 | -78.1% | 44,800 | -71.7% | 0.01% | -80.6% |
Q2 2020 | $1,080,000 | +99.3% | 158,100 | -55.0% | 0.07% | +157.1% |
Q1 2020 | $542,000 | +54100.0% | 351,128 | +26909.8% | 0.03% | – |
Q1 2018 | $1,000 | 0.0% | 1,300 | -13.3% | 0.00% | – |
Q4 2017 | $1,000 | -97.2% | 1,500 | -95.7% | 0.00% | -100.0% |
Q3 2017 | $36,000 | -37.9% | 34,650 | +17.8% | 0.00% | -50.0% |
Q2 2017 | $58,000 | +286.7% | 29,414 | -3.9% | 0.00% | +100.0% |
Q1 2017 | $15,000 | -61.5% | 30,600 | -64.3% | 0.00% | 0.0% |
Q4 2016 | $39,000 | -49.4% | 85,596 | +48.1% | 0.00% | -75.0% |
Q3 2016 | $77,000 | -45.4% | 57,796 | -56.2% | 0.00% | -42.9% |
Q2 2016 | $141,000 | -19.4% | 131,996 | +40.6% | 0.01% | -41.7% |
Q1 2016 | $175,000 | +13.6% | 93,870 | +89.0% | 0.01% | +50.0% |
Q4 2015 | $154,000 | – | 49,654 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON ASSOCIATES LP | 784,679 | $643,437 | 0.10% |
Green Alpha Advisors, LLC | 146,300 | $119,966 | 0.08% |
Virtus ETF Advisers LLC | 54,106 | $44,367 | 0.02% |
Cedar Brook Financial Partners, LLC | 104,881 | $86,002 | 0.02% |
PROFUND ADVISORS LLC | 418,749 | $343,374 | 0.02% |
Arlington Capital Management, Inc. | 27,735 | $22,743 | 0.02% |
Hennion & Walsh Asset Management, Inc. | 382,158 | $313 | 0.02% |
Rafferty Asset Management, LLC | 2,647,927 | $2,171,300 | 0.02% |
Brainard Capital Management LLC | 16,666 | $13,666 | 0.01% |
Beck Bode, LLC | 41,218 | $33,799 | 0.01% |